Tianjin Nine-An Medical Electronics Co., Ltd.
2025 Annual Independent Director's Performance Report
As an independent director of Tianjin Nine-An Medical Electronics Co., Ltd. (hereinafter referred to as the "Company"), I have strictly complied with the "Company Law," "Administrative Measures for Independent Directors of Listed Companies," "Shenzhen Stock Exchange Main Board Listed Company Normative Operation Guide No. 1," and other relevant laws and regulations, as well as the Company's Articles of Association, Rules of Procedure for Board of Directors Meetings, and Independent Director System. Throughout the year, I have upheld the principles of objectivity, independence, and prudence in fulfilling my duties, diligently performing all responsibilities of an independent director. During this period, I deeply participated in the Company's major operational and decision-making matters, fully leveraging my role in supervision and advice. I rigorously ensured the legality and scientific validity of decisions, continuously promoting the Company's standardized governance and effectively safeguarding the legitimate rights and interests of all shareholders, especially minority shareholders. The following is my performance report for 2025:
I. Basic Information of Independent Director
Bi Xiaofang: Female, born in December 1978, Chinese national, with no permanent overseas residency. Holds a doctoral degree. Professor at the School of Accounting, Tianjin University of Finance and Economics, and doctoral supervisor. Currently serves as an independent director of the Company. She also serves as an independent director of Tianjin Jin Investment Urban Development Co., Ltd., and an external director of Tianjin Heping Investment Development Group Co., Ltd. and Tianjin Heping Urban Development Group Co., Ltd.